Mechanistically, it inhibited NLRP3 inflammasome activation by upregulating SIRT1 expression, thereby reducing cardiac inflammatory infiltration, myocardial fibrosis, and cardiomyocyte apoptosis, ultimately mitigating DOX-induced cardiac injury (150). The gene discussed is NLRP3; the disease is Myocardial fibrosis.